DeepMed Research

Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain

Phase 2

Withdrawn

Conditions: Compliance
Chronic Pain

Interventions: Drug: acetazolamide
Drug: Quinine
Drug: Riboflavin

First Posted Date: 2014-10-28

Last Posted Date: 2017-02-10

Lead Sponsor: Georgetown University

Registration Number: NCT02276989

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Children With Diabetes at Risk for Heart Disease.

Conditions: Diabetes Mellitus, Type 1
Diabetes Complications

First Posted Date: 2014-10-27

Last Posted Date: 2019-04-05

Lead Sponsor: Georgetown University

Target Recruit Count: 240

Registration Number: NCT02275091

Locations: 🇺🇸
Georgetown-Howard Universities Center, Washington, District of Columbia, United States

Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

Phase 3

Completed

Conditions: Lung Cancer
Smoking

Interventions: Behavioral: Telephone Counseling
Behavioral: Minimal Treatment

First Posted Date: 2014-10-17

Last Posted Date: 2016-10-19

Lead Sponsor: Georgetown University

Target Recruit Count: 95

Registration Number: NCT02267096

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
Lahey Hospital and Medical Center, Burlington, Massachusetts, United States
🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Phase 1

Terminated

Conditions: Cancer
Small Cell Lung Cancer

Interventions: Drug: Ganetespib
Drug: Doxorubicin

First Posted Date: 2014-10-10

Last Posted Date: 2018-04-23

Lead Sponsor: Georgetown University

Target Recruit Count: 11

Registration Number: NCT02261805

Locations: 🇺🇸
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Not Applicable

Completed

Conditions: Side-effects
Prostate Cancer
Physical Activity

Interventions: Behavioral: Stretching Control Group
Behavioral: Supervised and Home Based Exercise

First Posted Date: 2014-09-25

Last Posted Date: 2018-02-15

Lead Sponsor: Georgetown University

Target Recruit Count: 19

Registration Number: NCT02248350

Locations: 🇺🇸
Office of Minority Health and Health Disparities Research, Washington, District of Columbia, United States

Study of Gemcitabine and Abraxane for Pancreas Cancer

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: Gemcitabine and Abraxane

First Posted Date: 2014-09-17

Last Posted Date: 2017-02-14

Lead Sponsor: Georgetown University

Target Recruit Count: 4

Registration Number: NCT02242409

Locations: 🇺🇸
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

Not Applicable

Completed

Conditions: Breast Cancer
Quality of Life

Interventions: Behavioral: Nueva Vida Intervention

First Posted Date: 2014-08-21

Last Posted Date: 2019-06-03

Lead Sponsor: Georgetown University

Target Recruit Count: 272

Registration Number: NCT02222337

Locations: 🇺🇸
Latinas Contra Cancer, San Jose, California, United States
🇺🇸
Gilda's Club New York City, New York, New York, United States
🇺🇸
SHARE, New York, New York, United States

and more 1 locations

Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Phase 1

Terminated

Conditions: Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions: Drug: Lenalidomide, Ibrutinib, Rituximab

First Posted Date: 2014-07-25

Last Posted Date: 2018-01-12

Lead Sponsor: Georgetown University

Target Recruit Count: 5

Registration Number: NCT02200848

Locations: 🇺🇸
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

Exergaming Intervention and Breast Cancer Biomarkers in Black Women

Phase 2

Completed

Conditions: Obesity
Breast Cancer

Interventions: Other: Exergaming

First Posted Date: 2014-06-02

Last Posted Date: 2020-02-10

Lead Sponsor: Georgetown University

Target Recruit Count: 150

Registration Number: NCT02152462

Locations: 🇺🇸
Georgetown Lombardi Office of Minority Health & Health Disparities Research, Washington, District of Columbia, United States

Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility

Not Applicable

Completed

Conditions: Ovarian Cancer
Breast Cancer

Interventions: Behavioral: Print DA
Behavioral: Inconclusive Results DA
Behavioral: Enhanced Print DA
Behavioral: Internet DA
Behavioral: Enhanced Internet DA

First Posted Date: 2014-05-08

Last Posted Date: 2022-10-14

Lead Sponsor: Georgetown University

Target Recruit Count: 369

Registration Number: NCT02133703

Locations: 🇺🇸
Georgetown University Medical Center/Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy